TSMC Posts Record Q1 Profit Fueled by AI Chip Demand 
KKR's $820M Investment Fuels Samsung SDS AI Expansion, Sending Group Shares Soaring 
CSN's Cement Unit Sale Could Exceed $2 Billion as Global Giants Circle 
Netflix Q2 Profit Warning Sends Shares Tumbling as Reed Hastings Exits 
Elon Musk's Terafab Foundry Courts Top Chipmaking Giants for AI Self-Sufficiency Push 
OpenAI's $20 Billion Cerebras Deal Signals Massive AI Infrastructure Push 
Qantas Raises Fuel Cost Forecast Amid Middle East Oil Crisis 
Amazon in Advanced Talks to Acquire Globalstar in Starlink Rivalry Move 
AEVEX Raises $320 Million in IPO Amid Surging Defense Sector Demand 
Federal Judge Dismisses DOJ Lawsuit Attempting to Block Hawaii's Climate Case Against Oil Giants 
Japan Opens Arms Export Floodgates: New Policy Draws Global Defense Interest 
Federal Agencies Secretly Test Anthropic's AI Despite Trump Administration Ban 
Texas AG Investigates Lululemon Over "Forever Chemicals" in Activewear 
ASML Raises 2026 Revenue Outlook as AI Chip Demand Surges 
Daikin Industries Stock Surges 14% After Elliott Investment Management Discloses Major Stake 
Japan to Subsidize Sony's Image Sensor Plant in Kumamoto with $380 Million 
Tesla's Terafab: AI Chip Factory Eyes Taiwan's Semiconductor Talent 
MOSCOW, May 31, 2017 -- Atlant Clinical LLC will host two first MedDRA trainings in Russia. The trainings will take place at Atlant Clinical’s Moscow office on June 5-6, 2017 and will cover coding and safety data analysis as well as SMQs. Jane Knight, an experienced MSSO instructor, will lead both programs. The events will be free of charge for registered MedDRA users.
By hosting the event, Atlant confirms its leading position in the field of professional trainings for clinical research specialists. Being a MedDRA member, Atlant Clinical applies clinical trial and regulatory international dictionaries in its everyday work, which allows it to be fully compliant with major global standards.
Mikhail Groubman, CEO, said: “We are proud to become the host of the first MedDRA Trainings in Russia. Atlant Clinical supports the process of clinical data and medical terminology standards implementation. Unified international standards help to analyze, report, and submit clinical data in strict accordance with ICH GCP and regulatory requirements.
We constantly invest in our team, conducting regular internal trainings and ensuring its ongoing development and outstanding professionalism. We are happy to share such an opportunity not just with our employees but with more than 50 professionals throughout the country, who have already signed up for the trainings.”
About Atlant Clinical
Atlant Clinical is an international CRO, established in 2007, offering a full range of clinical trial and relevant support services throughout the US, Europe, Russia, and Middle Asia. Atlant Clinical has extensive clinical experience (Phases I–IV) in over 15 therapeutic areas. The team consists of over 150 experienced employees worldwide. Atlant Clinical has offices in Russia, the US, Germany, the UK, Lithuania, and Ukraine. The company’s clients range from some of the world's leading pharmaceutical companies to new and growing biotech firms.
Contact To learn more about the trainings or Atlant Clinical, please contact: Marietta Sarkisyan, Business Development Manager 76 N. Walnut Street Ridgewood, NJ 07450 Phone: +1 (201) 616 00 37 [email protected]
